WASHINGTON (Reuters) -Robert F. Kennedy Jr., President Donald Trump's pick to lead the top U.S. health agency, came under ...

Novavax Inc. closed 62.24% below its 52-week high of $23.86, which the company reached on June 6th.

After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

The most recent trading session ended with Novavax (NVAX) standing at $9.34, reflecting a +1.3% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily loss of 1.46%.

Novavax Inc. closed 60.94% below its 52-week high of $23.86, which the company reached on June 6th.

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Concrete Pumping Holdings, Inc. BBCP: This concrete ...

Bullish option flow detected in Novavax (NVAX) with 5,702 calls trading, 1.1x expected, and implied vol increasing almost 10 points to 99.21%.

Robert F. Kennedy Jr., President Donald Trumps nominee to lead the U.S. Department of Health and Human Services (HHS), faced ...

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

The global vaccines market is projected to grow by $194 billion from 2025 to 2029, with an annual growth rate of nearly 23%, according to a report by Technavio. The expansion is fueled by increased ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced progress in Q4 2024 advancing its corporate growth strategy through ...

HWGAX’s 3-year and 5-year annualized returns are 7% and 9%, respectively. HWGAX has a Zacks Mutual Fund Rank #1. Its net expense ratio is 1.20%. Hotchkis & Wiley Small Cap Value Fund invests the ...